Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism


Author index

Page Path
Ahmed Al-Sharefi 1 Article
Hypothalamus and Pituitary gland
Current National and International Guidelines for the Management of Male Hypogonadism: Helping Clinicians to Navigate Variation in Diagnostic Criteria and Treatment Recommendations
Ahmed Al-Sharefi, Richard Quinton
Endocrinol Metab. 2020;35(3):526-540.   Published online September 22, 2020
  • 7,742 View
  • 394 Download
  • 11 Citations
AbstractAbstract PDFPubReader   ePub   CrossRef-TDMCrossref - TDM
Male hypogonadism—rebadged by some as testosterone deficiency syndrome—is a clinical and biochemical diagnosis of increasing worldwide interest. Organic male hypogonadism—usually permanent—is well-established, but aging men may also exhibit lower serum testosterone levels; principally due to burden of extra-gonadal comorbidities such as obesity, diabetes and metabolic syndrome, but with an underlying intact hypothalamo-pituitary-testicular (HPT) axis capable of springing back into operation once comorbidities are addressed. Despite encouraging observational data and plausible theoretical underpinning, evidence for efficacy and safety of testosterone in this “aging” group of men is lacking; addressing comorbid illnesses remains the key priority instead. Nevertheless, in recent years, accumulation of misleading information online has triggered a global tsunami of testosterone prescriptions. Despite this, many men with organic hypogonadism remain undiagnosed or untreated; many more face a diagnostic odyssey before achieving care by the appropriate specialist. As testosterone therapy is not without risk several clinical practice guidelines have been published specialist societies to guide physicians on best practice. However, these are heterogeneous in key areas, reflecting divergent approaches to the same evidence basis. Herein, we navigate the major clinical practice guidelines on male hypogonadism and test their respective recommendations against current best evidence.


Citations to this article as recorded by  
  • Expert Opinion on the Diagnosis and Management of Male Hypogonadism in India
    Sanjay Kalra, Jubbin Jacob, A. G. Unnikrishnan, Ganapathi Bantwal, Abhay Sahoo, Rakesh Sahay, Sushil Jindal, Madhu Sudan Agrawal, Nitin Kapoor, Banshi Saboo, Mangesh Tiwaskar, Kapil Kochhar, Henrik Falhammar
    International Journal of Endocrinology.2023; 2023: 1.     CrossRef
  • Management Outcomes in Males With Hypogonadotropic Hypogonadism Treated With Gonadotropins
    Bahaa O Sahib, Ibrahim H Hussein, Nassar T Alibrahim, Abbas A Mansour
    Cureus.2023;[Epub]     CrossRef
  • The Association between Inflammation, Testosterone and SHBG in men: A cross‐sectional Multi‐Ethnic Study of Atherosclerosis
    Amar Osmancevic, Bledar Daka, Erin D. Michos, Penelope Trimpou, Matthew Allison
    Clinical Endocrinology.2023; 99(2): 190.     CrossRef
  • The Illusory Case for Treatment of an Invented Disease
    David J. Handelsman
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Effect of Chronic Heart Failure Complicated with Type 2 Diabetes Mellitus on Cognitive Function in the Elderly
    Yang Liu, Rui Meng, Jianzeng Dong, Xiaonan Xi
    Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
  • Different Factors Are Associated With Sex Hormones and Leydig Cell Function in Israelis and Palestinians in Jerusalem
    Guy Vishnevsky, Ronit Sinnreich, Hisham Nassar, Dafna Merom, Maya Ish-Shalom, Jeremy D. Kark, Hagai Levine
    American Journal of Men's Health.2022; 16(4): 155798832211060.     CrossRef
  • Association of rs9939609 polymorphism in the FTO gene with features of androgen status in men
    S. V. Yankovskaya, K. I. Mosalev, I. D. Ivanov, B. B. Pinkhasov, V. G. Selyatitskaya
    Сибирский научный медицинский журнал.2022; 42(2): 18.     CrossRef
  • Clinical and pharmacological basis of the use of testosterone drugs for hormonal replacement therapy for hypogonadism in men
    N. I. Volkova, A. V. Safronenko, E. V. Gantsgorn, Yu. S. Degtyareva
    Obesity and metabolism.2022; 19(2): 233.     CrossRef
  • Monitoring and Management of Bardet-Biedl Syndrome: What the Multi-Disciplinary Team Can Do
    Lavinia Caba, Laura Florea, Elena Emanuela Braha, Valeriu Vasile Lupu, Eusebiu Vlad Gorduza
    Journal of Multidisciplinary Healthcare.2022; Volume 15: 2153.     CrossRef
  • Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones
    Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Helda Tutunchi
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
    Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, Giovanni Corona, Stefan Arver, Svetlana Kalinchenko, Yuliya Tishova, Abraham Morgentaler
    The Aging Male.2021; 24(1): 119.     CrossRef

Endocrinol Metab : Endocrinology and Metabolism